ClinicaliQ Trial Snapshot
- THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE) — Recruiting • Phase IV • Cardiology / Cardiovascular • NCT05735639.
- Treatment being tested: Thromboprophylaxis (blood clot prevention strategies) in patients undergoing endovenous interventions for superficial varicose veins, which are minimally invasive keyhole procedures performed within the vein itself.
- Patient eligibility overview: The trial includes individuals with varicose veins requiring endovenous treatment, with connections between superficial and deeper leg veins; specific inclusion/exclusion criteria would define baseline characteristics and risk profiles.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Endovenous interventions are keyhole operations for varicose veins that are carried out from within the vein itself. Varicose veins are enlarged veins close to the surface of the skin. They are connected to the bigger deeper veins in the leg (known as deep veins). Because of this, operations to close the varicose veins can increase the chance of a blood clot forming in the deep veins. Blood clots in the deep veins happen in around 1 in 50 people after endovenous operations. A clot in the leg can cause swelling,…
Eligibility Snapshot
- : * Adults (>18 years) * Scheduled to undergo endovenous intervention of truncal varicose veins under local anaesthesia * Treatment technologies including radiofrequency, laser, mechanochemical, foam sclerotherapy and cyanoacrylate glue
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.